The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers
Anna L. Bruckner(Children's Hospital Colorado), Dédée F. Murrell(Sutherland Hospital), Jayson Wisk(Amicus Therapeutics (United States)), Hjalmar Lagast(Amicus Therapeutics (United States)), Nita Patel(Amicus Therapeutics (United States)), Jayne Gershkowitz(Amicus Therapeutics (United States)), Michael Hund, Brett Kopelan(Dystrophic Epidermolysis Bullosa Research Association of America), Michael Losow(Amicus Therapeutics (United States)), A. Reha(Amicus Therapeutics (United States)), Jamie Gault(Amicus Therapeutics (United States))
Cited by 185
Related Papers
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
|Journal of the American Academy of Dermatology|2014|933
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
|Journal of the American Academy of Dermatology|2008|933
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
|British Journal of Dermatology|2020|778
Yeast Two-Hybrid, a Powerful Tool for Systems Biology
|International Journal of Molecular Sciences|2009|602
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586